Abbott Laboratories (ABT) 41.90 $ABT Global Inf
Post# of 273246
Posted On: 09/08/2016 1:03:47 AM
Abbott Laboratories (ABT) 41.90 $ABT
Global Influenza Market Worth USD 10.2 Billion by 2022 - Analysis, Technologies & Forecasts Report 2016-2022 - Key Vendors: Abbott Labs, CSL, Roche Holding - Research and Markets
BusinessWire - Thu Sep 01, 6:41AM CDT
Research and Markets has announced the addition of the "Global Influenza Market - Vaccines and Therapeutics" report to their offering.
ABT: 41.90 (-0.26)
Post Earnings Coverage as Medtronic Earnings Surge 13 Percent on Lower Tax Bill
ACCESSWIRE - Tue Aug 30, 8:16AM CDT
LONDON, UK / ACCESSWIRE / August 30, 2016 / Active Wall St. announces its post-earnings coverage on Medtronic PLC (NYSE: MDT). The company reported its first quarter fiscal 2016 results on August 25, 2016. The world's largest standalone medical device maker reported better-than-expected quarterly earnings, despite a drop in sales. Register with us now for your free membership at: http://www.activewallst.com/register/.
ABT: 41.90 (-0.26), MDT: 86.15 (-1.02), STJ: 79.18 (+0.28)
Research Report on Medical Appliances & Equipment Equities -- Abbott Laboratories, Boston Scientific, Medtronic, and Hologic
PR Newswire - Tue Aug 30, 6:35AM CDT
The Medical Appliances and Equipment industry includes companies that manufacture medical instruments such as dental and surgical appliances. Stocks in this space tend to offer below-average dividend yields when compared to the wider market. Stock-Callers.com now reviews the recent performances of the following equities: Abbott Laboratories (NYSE: ABT), Boston Scientific Corp. (NYSE: BSX), Medtronic PLC (NYSE: MDT), and Hologic Inc. (NASDAQ: HOLX). Learn more about these stocks by accessing their free research reports at:
BSX: 24.41 (+0.08), ABT: 41.90 (-0.26), MDT: 86.15 (-1.02), HOLX: 38.67 (+0.17)
Stock Market News for August 29, 2016
Zacks Equity Research - Zacks Investment Research - Mon Aug 29, 9:10AM CDT
Benchmarks ended a choppy trading session mostly in the red on Friday as investors continued to grapple with the timing of a rate hike
ABT: 41.90 (-0.26), YHOO: 44.35 (-0.36), NEE: 125.06 (-0.23), TERP: 13.56 (-0.01), DUK: 80.54 (-0.40), FB: 131.05 (+1.32), SNP: 73.49 (+0.04), VFC: 60.62 (+0.84), ALR: 42.35 (+2.28)
Abbott Labs Sued by Alere over Pending $5.8B Acquisition
Zacks Equity Research - Zacks Investment Research - Mon Aug 29, 7:38AM CDT
Abbott Labs (ABT) was sued by Alere (ALR) in the latter's attempt to force the former to complete the $5.8 billion takeover.
ABT: 41.90 (-0.26), ANIP: 60.71 (-0.84), ALR: 42.35 (+2.28)
Nestle, Mead Johnson, Danone, Abbott Laboratories and FrieslandCampina Dominate the Global Infant Nutrition Market
PR Newswire Europe - Thu Aug 25, 7:31AM CDT
HYDERABAD, India, August 25, 2016 /PRNewswire/ --
ABT: 41.90 (-0.26)
Fresenius SE & Co. KGaA, Abbott Laboratories and Covidien PLC to Gain Exponentially From the Global Enteral Feeding Device Market
PR Newswire Europe - Wed Aug 24, 8:31AM CDT
HYDERABAD, India, August 24, 2016 /PRNewswire/ --
ABT: 41.90 (-0.26)
Medical Device Leader Series: Top Companion Diagnostics (CDx) Developers, Manufacturers and Marketers in 2016
PR Newswire Europe - Wed Aug 24, 8:02AM CDT
LONDON, August 24, 2016 /PRNewswire/ --
JNJ: 119.61 (-0.14), ABT: 41.90 (-0.26), MYGN: 20.32 (-0.35), A: 47.11 (+0.16)
Abbott to Present at Wells Fargo Healthcare Conference
PR Newswire - Wed Aug 24, 8:00AM CDT
Abbott (NYSE: ABT) will present at the Wells Fargo 2016 Healthcare Conference on Wednesday, Sept. 7, 2016. Brian Yoor, senior vice president, finance and chief financial officer, will present at 7:45 a.m. Central time.
ABT: 41.90 (-0.26), WFC: 49.77 (-0.22)
Pfizer spends $14B on Medivation in cancer fight
By TOM MURPHY and LINDA A. JOHNSON - AP - Mon Aug 22, 10:46AM CDT
Pfizer will pay about $14 billion to buy cancer drug developer Medivation in a cash deal aimed at fortifying its hold in one of the hottest and most lucrative areas of medicine.
MDVN: 80.97 (+0.13), AGN: 238.42 (-0.70), ABT: 41.90 (-0.26), PFE: 34.84 (+0.07)
Medtronic Launches MiniMed 630G, Expands in Diabetic Care (revised)
Zacks Equity Research - Zacks Investment Research - Mon Aug 15, 4:34PM CDT
The MiniMed 630G basically combines SmartGuard technology which is already featured in the MiniMed 530G system with a brand new user-friendly design.
ABT: 41.90 (-0.26), BDX: 177.76 (-0.12), DXCM: 95.01 (+0.73), MDT: 86.15 (-1.02)
Medtronic Launches MiniMed 630G, Expands in Diabetic Care
Zacks Equity Research - Zacks Investment Research - Mon Aug 15, 9:15AM CDT
Medtronic plc's (MDT) MiniMed 630G system with SmartGuard technology recently won the U.S. FDA approval for its commercial launch.
ABT: 41.90 (-0.26), BDX: 177.76 (-0.12), DXCM: 95.01 (+0.73), MDT: 86.15 (-1.02)
Abbott Laboratories (ABT) Crosses Pivot Point Support at $44.82
Comtex SmarTrend(R) - Fri Aug 12, 9:23AM CDT
Shares of Abbott Laboratories (NYSE:ABT) have bearishly opened below the pivot of $44.98 today and have reached the first support level of $44.82. Should the shares continue to fall, the support pivots of $44.59 and $44.20 will be of interest.
ABT: 41.90 (-0.26)
Identifying Newest Cannabis Strains for Cancer Treatment and Other Ailments Gain Headway Behind Pharmacological Evaluations
PR Newswire Europe - Wed Aug 10, 7:31AM CDT
CORAL SPRINGS, Florida, August 10, 2016 /PRNewswire/ --
ABT: 41.90 (-0.26), INSY: 15.71 (+0.78), CGC.TO: 3.98 (+0.13), GWPH: 104.03 (+19.83)
Global Blood Screening Market Worth USD 4.8 Billion by 2025 - Analysis, Technologies & Forecasts Report 2016-2025 - Key Vendors: Abbott Labs, Luminex, Trinity Biotech - Research and Markets
BusinessWire - Mon Aug 08, 7:03AM CDT
Research and Markets has announced the addition of the "Global Blood Screening Market Analysis & Trends - Industry Forecast to 2025" report to their offering.
ABT: 41.90 (-0.26)
Global Influenza Market Worth USD 10.2 Billion by 2022 - Analysis, Technologies & Forecasts Report 2016-2022 - Key Vendors: Abbott Labs, CSL, Roche Holding - Research and Markets
BusinessWire - Thu Sep 01, 6:41AM CDT
Research and Markets has announced the addition of the "Global Influenza Market - Vaccines and Therapeutics" report to their offering.
ABT: 41.90 (-0.26)
Post Earnings Coverage as Medtronic Earnings Surge 13 Percent on Lower Tax Bill
ACCESSWIRE - Tue Aug 30, 8:16AM CDT
LONDON, UK / ACCESSWIRE / August 30, 2016 / Active Wall St. announces its post-earnings coverage on Medtronic PLC (NYSE: MDT). The company reported its first quarter fiscal 2016 results on August 25, 2016. The world's largest standalone medical device maker reported better-than-expected quarterly earnings, despite a drop in sales. Register with us now for your free membership at: http://www.activewallst.com/register/.
ABT: 41.90 (-0.26), MDT: 86.15 (-1.02), STJ: 79.18 (+0.28)
Research Report on Medical Appliances & Equipment Equities -- Abbott Laboratories, Boston Scientific, Medtronic, and Hologic
PR Newswire - Tue Aug 30, 6:35AM CDT
The Medical Appliances and Equipment industry includes companies that manufacture medical instruments such as dental and surgical appliances. Stocks in this space tend to offer below-average dividend yields when compared to the wider market. Stock-Callers.com now reviews the recent performances of the following equities: Abbott Laboratories (NYSE: ABT), Boston Scientific Corp. (NYSE: BSX), Medtronic PLC (NYSE: MDT), and Hologic Inc. (NASDAQ: HOLX). Learn more about these stocks by accessing their free research reports at:
BSX: 24.41 (+0.08), ABT: 41.90 (-0.26), MDT: 86.15 (-1.02), HOLX: 38.67 (+0.17)
Stock Market News for August 29, 2016
Zacks Equity Research - Zacks Investment Research - Mon Aug 29, 9:10AM CDT
Benchmarks ended a choppy trading session mostly in the red on Friday as investors continued to grapple with the timing of a rate hike
ABT: 41.90 (-0.26), YHOO: 44.35 (-0.36), NEE: 125.06 (-0.23), TERP: 13.56 (-0.01), DUK: 80.54 (-0.40), FB: 131.05 (+1.32), SNP: 73.49 (+0.04), VFC: 60.62 (+0.84), ALR: 42.35 (+2.28)
Abbott Labs Sued by Alere over Pending $5.8B Acquisition
Zacks Equity Research - Zacks Investment Research - Mon Aug 29, 7:38AM CDT
Abbott Labs (ABT) was sued by Alere (ALR) in the latter's attempt to force the former to complete the $5.8 billion takeover.
ABT: 41.90 (-0.26), ANIP: 60.71 (-0.84), ALR: 42.35 (+2.28)
Nestle, Mead Johnson, Danone, Abbott Laboratories and FrieslandCampina Dominate the Global Infant Nutrition Market
PR Newswire Europe - Thu Aug 25, 7:31AM CDT
HYDERABAD, India, August 25, 2016 /PRNewswire/ --
ABT: 41.90 (-0.26)
Fresenius SE & Co. KGaA, Abbott Laboratories and Covidien PLC to Gain Exponentially From the Global Enteral Feeding Device Market
PR Newswire Europe - Wed Aug 24, 8:31AM CDT
HYDERABAD, India, August 24, 2016 /PRNewswire/ --
ABT: 41.90 (-0.26)
Medical Device Leader Series: Top Companion Diagnostics (CDx) Developers, Manufacturers and Marketers in 2016
PR Newswire Europe - Wed Aug 24, 8:02AM CDT
LONDON, August 24, 2016 /PRNewswire/ --
JNJ: 119.61 (-0.14), ABT: 41.90 (-0.26), MYGN: 20.32 (-0.35), A: 47.11 (+0.16)
Abbott to Present at Wells Fargo Healthcare Conference
PR Newswire - Wed Aug 24, 8:00AM CDT
Abbott (NYSE: ABT) will present at the Wells Fargo 2016 Healthcare Conference on Wednesday, Sept. 7, 2016. Brian Yoor, senior vice president, finance and chief financial officer, will present at 7:45 a.m. Central time.
ABT: 41.90 (-0.26), WFC: 49.77 (-0.22)
Pfizer spends $14B on Medivation in cancer fight
By TOM MURPHY and LINDA A. JOHNSON - AP - Mon Aug 22, 10:46AM CDT
Pfizer will pay about $14 billion to buy cancer drug developer Medivation in a cash deal aimed at fortifying its hold in one of the hottest and most lucrative areas of medicine.
MDVN: 80.97 (+0.13), AGN: 238.42 (-0.70), ABT: 41.90 (-0.26), PFE: 34.84 (+0.07)
Medtronic Launches MiniMed 630G, Expands in Diabetic Care (revised)
Zacks Equity Research - Zacks Investment Research - Mon Aug 15, 4:34PM CDT
The MiniMed 630G basically combines SmartGuard technology which is already featured in the MiniMed 530G system with a brand new user-friendly design.
ABT: 41.90 (-0.26), BDX: 177.76 (-0.12), DXCM: 95.01 (+0.73), MDT: 86.15 (-1.02)
Medtronic Launches MiniMed 630G, Expands in Diabetic Care
Zacks Equity Research - Zacks Investment Research - Mon Aug 15, 9:15AM CDT
Medtronic plc's (MDT) MiniMed 630G system with SmartGuard technology recently won the U.S. FDA approval for its commercial launch.
ABT: 41.90 (-0.26), BDX: 177.76 (-0.12), DXCM: 95.01 (+0.73), MDT: 86.15 (-1.02)
Abbott Laboratories (ABT) Crosses Pivot Point Support at $44.82
Comtex SmarTrend(R) - Fri Aug 12, 9:23AM CDT
Shares of Abbott Laboratories (NYSE:ABT) have bearishly opened below the pivot of $44.98 today and have reached the first support level of $44.82. Should the shares continue to fall, the support pivots of $44.59 and $44.20 will be of interest.
ABT: 41.90 (-0.26)
Identifying Newest Cannabis Strains for Cancer Treatment and Other Ailments Gain Headway Behind Pharmacological Evaluations
PR Newswire Europe - Wed Aug 10, 7:31AM CDT
CORAL SPRINGS, Florida, August 10, 2016 /PRNewswire/ --
ABT: 41.90 (-0.26), INSY: 15.71 (+0.78), CGC.TO: 3.98 (+0.13), GWPH: 104.03 (+19.83)
Global Blood Screening Market Worth USD 4.8 Billion by 2025 - Analysis, Technologies & Forecasts Report 2016-2025 - Key Vendors: Abbott Labs, Luminex, Trinity Biotech - Research and Markets
BusinessWire - Mon Aug 08, 7:03AM CDT
Research and Markets has announced the addition of the "Global Blood Screening Market Analysis & Trends - Industry Forecast to 2025" report to their offering.
ABT: 41.90 (-0.26)
(0)
(0)Scroll down for more posts ▼